Are we missing opportunities for early Influenza treatment in Immunocompromised Hosts? Are we missing opportunities for early Influenza treatment in Immunocompromised Hosts?
Choosing Short Term Cost Savings over Long Term Prevention: The Antifungal Prevention Paradox in AML Choosing Short Term Cost Savings over Long Term Prevention: The Antifungal Prevention Paradox in AML
Infections in Cancer, Transplantation and the Compromised Host 